China Achieves World-First in Reversing Diabetes with Stem Cell Therapy 

In a groundbreaking medical advancement, Chinese scientists have successfully reversed type 1 diabetes in a patient using stem cell therapy—a global first that could revolutionize diabetes treatment.

A 25-year-old woman from Tianjin, who had battled type 1 diabetes for over a decade, underwent a minimally invasive procedure where her own fat cells were reprogrammed into insulin-producing islet cells. These cells were then transplanted into her abdominal muscles. Remarkably, within 2.5 months, she began producing sufficient insulin naturally, eliminating the need for external insulin injections. 

The procedure, lasting just 30 minutes, was conducted by researchers from Tianjin First Central Hospital and Peking University. The success of this autologous stem cell therapy—using the patient’s own cells—significantly reduces the risk of immune rejection and the necessity for lifelong immunosuppressive drugs. 

Over a year post-treatment, the patient maintains stable blood glucose levels without insulin therapy, with her blood sugar within the target range 98% of the time. 

This pioneering approach offers hope to millions worldwide affected by type 1 diabetes. While further research is needed to assess long-term efficacy and scalability, this achievement marks a significant milestone in regenerative medicine and diabetes care.